Travere Therapeutics Inc’s recently made public that its SENIOR VICE PRESIDENT, R&D ROTE WILLIAM E. unloaded Company’s shares for reported $50538.0 on Sep 09 ’24. In the deal valued at $11.52 per share,4,387 shares were sold. As a result of this transaction, ROTE WILLIAM E. now holds 84,455 shares worth roughly $ 1.09 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, REED ELIZABETH E sold 4,387 shares, generating $50,538 in total proceeds. Upon selling the shares at $11.52, the SVP, GC & CORPORATE SECRETARY now owns 78,633 shares.
Before that, Dube Eric M sold 21,125 shares. Travere Therapeutics Inc shares valued at $243,360 were divested by the CHIEF EXECUTIVE OFFICER at a price of $11.52 per share. As a result of the transaction, Dube Eric M now holds 361,975 shares, worth roughly $4.65 million.
Guggenheim upgraded its Travere Therapeutics Inc [TVTX] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who decreased its forecast for the stock in late March from “a Buy” to “a Neutral”. Citigroup also remained covering TVTX and has increased its forecast on December 05, 2023 with a “Buy” recommendation from previously “Neutral” rating. Citigroup started covering the stock on November 20, 2023. It rated TVTX as “a Neutral”.
Price Performance Review of TVTX
On Monday, Travere Therapeutics Inc [NASDAQ:TVTX] saw its stock jump 17.12% to $12.86. Over the last five days, the stock has gained 35.80%. Travere Therapeutics Inc shares have risen nearly 43.05% since the year began. Nevertheless, the stocks have fallen -9.12% over the past one year. While a 52-week high of $14.82 was reached on 09/09/24, a 52-week low of $5.12 was recorded on 04/25/24. SMA at 50 days reached $9.28, while 200 days put it at $8.03.
Levels Of Support And Resistance For TVTX Stock
The 24-hour chart illustrates a support level at 11.85, which if violated will result in even more drops to 10.85. On the upside, there is a resistance level at 13.51. A further resistance level may holdings at 14.17. The Relative Strength Index (RSI) on the 14-day chart is 83.79, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.65, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 6.38%. Stochastics %K at 81.41% indicates the stock is a selling.
How much short interest is there in Travere Therapeutics Inc?
A steep rise in short interest was recorded in Travere Therapeutics Inc stocks on 2024-08-15, dropping by -0.8 million shares to a total of 9.3 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 10.1 million shares. There was a decline of -8.65%, which implies that there is a negative sentiment for the stock.
